Distinct phenotypes in mixed connective tissue disease: Subgroups and survival

Lupus

Volumn 21, Issue 13, 2012, Pages 1412-1422

  Szodoray, P ^a   Hajas, A ^b   Kardos, L ^c   Dezso, B ^b   Soos, G ^b   Zold, E ^b   Vegh, J ^b   Csipo, I ^b   Nakken, B ^a   Zeher, M ^b   Szegedi, G ^b   Bodolay, E ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c Kenezy County Hospital   (Hungary)

Author keywords

autoantibodies; cluster analysis; Mixed connective tissue disease; phenotypes

Indexed keywords

CARDIOLIPIN ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ENDOTHELIAL CELL ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; U1RNP ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRACTURE; GASTROINTESTINAL DISEASE; HUMAN; INTERSTITIAL LUNG DISEASE; LIVEDO RETICULARIS; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MUSCULOSKELETAL INJURY; MYOSITIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SURVIVAL; VEIN THROMBOSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTHRITIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; HUMANS; HUNGARY; HYPERTENSION, PULMONARY; INCIDENCE; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; PHENOTYPE; PREVALENCE; PROGNOSIS; RAYNAUD DISEASE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84867826641     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312456751     Document Type: Article

References (38)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease- an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 ; 52: 148-159
2. Peterson I, Wang G, Smith EI, et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoprotein in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus: a cross-sectional, longitudinal study. Arthritis Rheum. 1986 ; 29: 986-996
3. Hoffmann RW, Cassidy JT, Takeda Y, Smith-Jones EL, Wang GS, Sharp GC. U1-70 kD autoantibody positive connective tissue disease in children: a longitudinal clinical and serological analysis. Arthritis Rheum. 1993 ; 36: 1599-1602
4. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be?. Arthritis Rheum. 1998 ; 41: 768-777
5. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies: a prospective study of 32 patients. J Rheumatol. 1991 ; 18: 1511-1519
6. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999 ; 42: 899-909
7. Prakash UBS. Respiratory complication in mixed connective tissue disease. Clin Chest Med. 1998 ; 19: 733-746
8. Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore). 1984 ; 63: 92-107
9. Grant KD, Adams LE, Hess EV. Mixed connective tissue disease-a subset with sequential clinical and laboratory features. J Rheumatol. 1981 ; 8: 587-598
10. Okawa-Takatsuji M, Aotsuka S, Uwatoko S, et al. Increase of cytokine production by pulmonary artery endothelial cells induced by supernatants from monocytes stimulated with autoantibodies against U1-ribonucleoprotein. Clin Exp Rheum. 1999 ; 17: 705-712
11. Bodolay E, Csipo I, Gal I, et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol. 2004 ; 22: 409-415
12. Nishimaki T, Aotsuka S, Kondo H, et al. Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol. 1999 ; 26: 2357-2362
13. Végh J, Szodoray P, Kappelmayer J, et al. Clinical and immunoserological characteristics of mixed connective issue disease associated with pulmonary arterial hypertension. Scand J Immunol. 2006 ; 64: 69-76
14. Udoff EJ, Genant HK, Kozin F, Ginsberg M. Mixed connective tissue disease: the spectrum of radiographic manifestations. Radiology. 1977 ; 124: 613-618
15. Takasaki Y, Yamanaka K, Takasaki C, et al. Anticyclic citrullinated peptide antibodies in patients in mixed connective tissue disease. Mod Rheumatol. 2004 ; 14: 367-375
16. Alarcon-Segovia D, Villarreal M Mixed connective tissue disease and anti-nuclear antibodies. Kasukawa R Sharp GC, ed. Amsterdam, Netherlands: Elsevier Science ; 1987: 33-40.
17. Gaál J, Varga J, Szabados L, Garai I, et al. High prevalence of oesophageal involvement in patients with undifferentiated connective tissue disease using radionuclide oesophageal transit scintigraphy. Nucl Med Commun. 2005 ; 26: 1113-1117
18. Maricq HR, Weinrich MC. Diagnosis of Raynaud's phenomenon assisted by color charts. J Rheumatol. 1988 ; 15: 454-459
19. Nagy Z, Czirjak L. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease. J Eur Acad Dermatol Venereol. 2004 ; 8: 62-68
20. Maricq HR. Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum. 1981 ; 24: 1159-1165
21. Lee P, Leung FY-K, Alderdice C, Armstrong SK. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol. 1983 ; 10: 930-938
22. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 ; 61: 554-558
23. Lu Y, Genant HK, Shepherd J, et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res. 2001 ; 16: 901-910
24. Baloch Z, Carayon P, Conte-Devolx B, et al. the Guidelines committee of the National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support of the diagnosis and monitoring of thyroid disease. Thyroid. 2003 ; 13: 3-126
25. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006 ; 4: 295-296
26. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/Americal College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
27. Aringer M, Smolen JS. Mixed connective tissue disease: what is behind the curtain?. Best Pract Res Clin Rheumatol. 2007 ; 21: 1037-1049
28. Maldonado ME, Perez M, Pignac-Kobinger J, et al. Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a midwestern US Caucasian population. J Rheumatol. 2008 ; 35: 1-9
29. Singsen BH, Swanson VL, Bernstein BH, Heuser ET, Hanson V, Landing BH. A histologic evaluation of mixed connective tissue disease in childhood. Am J Med. 1980 ; 68: 710-717
30. Prakash UBS, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc. 1985 ; 60: 813-821
31. Prakash UBS. Pulmonary manifestations in mixed connective tissue disease. Semin Resp Med. 1988 ; 9: 318-324
32. Bodolay E, Szekanecz Z, Dévényi K, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford). 2005 ; 44: 656-661
33. Kozuka T, Johkoh T, Honda O, et al. Pulmonary involvement in mixed connective tissue disease. High-resolution CT findings in 41 patients. J Thor Imaging. 2001 ; 16: 94-98
34. Ramos-Niembro F, Alarcon-Segovia D, Hernandez-Ortiz J. Articular manifestations of mixed connective tissue disease. Arthritis Rheum. 1979 ; 22: 43-51
35. Halla JT, Hardin JG. Clinical features of the arthritis of mixed connective tissue disease. Arthritis Rheum. 1978 ; 21: 497-503
36. Silver TM, Farber SJ, Bole GG, Martel W. Radiological features of mixed connective tissue disease and scleroderma-systemic lupus erythematosus overlap. Radiaology. 1976 ; 120: 269-275
37. Setty YN, Pittman CB, Mahale AS, Greidinger EL, Hoffman RW. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease. J Rheumatol. 2002 ; 29: 487-489
38. Bíro E, Szekanecz Z, Czirják L, et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol. 2006 ; 25: 240-245